Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.610
-0.230 (-12.50%)
At close: Aug 1, 2025, 4:00 PM
1.680
+0.070 (4.35%)
After-hours: Aug 1, 2025, 7:58 PM EDT
CTI BioPharma Market Cap
Pulmonx has a market cap or net worth of $64.81 million as of August 1, 2025. Its market cap has decreased by -78.86% in one year.
Market Cap
64.81M
Enterprise Value
37.42M
1-Year Change
-78.86%
Ranking
Category
Stock Price
$1.61
Market Cap Chart
Since the IPO on October 1, 2020, Pulmonx's market cap has decreased from $1.33B to $64.81M, a decrease of -95.14%. That is a compound annual growth rate of -46.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 74.07M | -72.37% |
| Dec 31, 2024 | 268.12M | -45.11% |
| Dec 29, 2023 | 488.43M | 54.88% |
| Dec 30, 2022 | 315.36M | -73.31% |
| Dec 31, 2021 | 1.18B | -52.01% |
| Dec 31, 2020 | 2.46B | 84.60% |
| Oct 1, 2020 | 1.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 680.48B |
| Johnson & Johnson | 398.44B |
| AbbVie | 341.20B |
| AstraZeneca | 232.21B |
| Novartis AG | 224.47B |
| UnitedHealth Group | 221.30B |
| Abbott Laboratories | 220.43B |
| Novo Nordisk | 213.92B |